Story perspectives
Revolutionary Antibiotic Innovations Target Multidrug-Resistant Infections
10/4/2025
1 of 1
Story summary
- SPR741 may act as an antibiotic adjuvant to boost Gram-negative drugs.
- Deep learning is used to discover new antibiotics targeting Acinetobacter baumannii.
- Colistin is re-emerging for multidrug-resistant infections, despite nephrotoxicity concerns.
- Gut microbiome interacts with antibiotics and relates to Crohn's disease.
- Antibiotic use is linked to Crohn's risk and infection exacerbation, underscoring the need for innovation.
